We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The primary complaint in FDA warning letters featuring corrective and preventive action (CAPA) citations is that, although the devicemaker had established CAPA procedures, it did not follow or document them properly.